Long Daniel D.
Long Daniel D., SVP, DD, reported a transaction classified as exercise at Septerna, Inc. involving 3333.000000 shares for an estimated $9199.08. Reported holdings after the transaction were 99745.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 01, 2026
- Filing date
- Sep 03, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
SEPN price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-382267 Common Stock
- Transaction date
- Sep 01, 2026 Filed Sep 03, 2026, 11:01 PM · 2d delay
- Shares
- 3,333 sh $2.76 per share
- Estimated value
- $9.19k Computed from shares × price
- Holdings after
- 99,745 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
SVP, Drug Discovery
- F1
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 20, 2026.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.34 to $38.21. The Reporting Person undertakes to provide to the Iss…
- F3
1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 1, 2024, subject to the Reporting Person'…
0 other transactions
0 recent txs